S9 Ep50: Lunning and Mehta-Shah Unpack Treatment Needs and Future Directions in PTCL

from OncLive® On Air · host OncLive® On Air

Dr Lunning and Neha Mehta-Shah, MD, MSCI, of Washington University School of Medicine, highlight challenges that arise when diagnosing patients with PTCL; how molecular testing results influence induction and consolidation treatment approaches for patients with ALK-negative anaplastic large cell lymphoma; and novel frontline agents under investigation in PTCL.

Episode metadata supplied by the publisher feed · Published Dec 21, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

S9 Ep50: Lunning and Mehta-Shah Unpack Treatment Needs and Future Directions in PTCL

0:00 17:26

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of OncLive® On Air?

This episode is 17 minutes long.

When was this OncLive® On Air episode published?

This episode was published on December 21, 2023.

Can I download this OncLive® On Air episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!